These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 6934089

  • 21. Influence of food on the rate and extent of absorption of theophylline after single dose oral administration of a controlled release tablet.
    Lagas M, Jonkman JH.
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):424-6. PubMed ID: 4044074
    [Abstract] [Full Text] [Related]

  • 22. Absorption properties of two theophylline sustained-release products in smokers.
    Miller R, Rheeders M.
    S Afr Med J; 1984 Jun 30; 65(26):1045-8. PubMed ID: 6740419
    [Abstract] [Full Text] [Related]

  • 23. Comparative steady-state bioavailability of Theo-24 and Theo-Dur in healthy men.
    Dockhorn RJ, Cefali EA, Straughn AB.
    Ann Allergy; 1994 Mar 30; 72(3):218-22. PubMed ID: 8129214
    [Abstract] [Full Text] [Related]

  • 24. Absorption of theophylline from enteric coated and sustained release formulations in fasted and non-fasted subjects.
    Osman MA, Patel RB, Irwin DS, Welling PG.
    Biopharm Drug Dispos; 1983 Mar 30; 4(1):63-72. PubMed ID: 6839003
    [Abstract] [Full Text] [Related]

  • 25. Relative bioavailability and release pattern of whole and halved sustained-release theophylline tablets.
    Leeds NH, Gal P, Purohit AA, Walter JB.
    Clin Pharm; 1982 Mar 30; 1(2):163-4. PubMed ID: 7185516
    [No Abstract] [Full Text] [Related]

  • 26. Bioavailability and pharmacological effects of two slow-release theophylline preparations: intrasubject tablet-to-tablet variability.
    Rivera-Calimlim L, Calimlim JF, Liang R, Lasagna L, Diamond GL.
    J Asthma; 1986 Mar 30; 23(3):113-22. PubMed ID: 3528119
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Bioavailability of four slow-release theophylline formulations in the beagle dog.
    Koritz GD, McKiernan BC, Neff-Davis CA, Munsiff IJ.
    J Vet Pharmacol Ther; 1986 Sep 30; 9(3):293-302. PubMed ID: 3761420
    [Abstract] [Full Text] [Related]

  • 29. [Theo-dur: sustained-release theophylline].
    Cuena Boy R, Azanza Perea JR, Honorato Pérez J.
    Rev Med Univ Navarra; 1984 Jun 30; 28(2):62-3. PubMed ID: 6494704
    [No Abstract] [Full Text] [Related]

  • 30. Theophylline absorption from two sustained-release products. Implications for therapeutic drug monitoring.
    Rogers RJ, Wiener MB, Hill MR, Szefler SJ.
    Am Rev Respir Dis; 1987 Nov 30; 136(5):1168-73. PubMed ID: 3674579
    [Abstract] [Full Text] [Related]

  • 31. Food-induced changes in theophylline absorption from controlled-release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo-Dur Sprinkle.
    Karim A, Burns T, Wearley L, Streicher J, Palmer M.
    Clin Pharmacol Ther; 1985 Jul 30; 38(1):77-83. PubMed ID: 4006379
    [Abstract] [Full Text] [Related]

  • 32. Comparative steady-state bioavailability of sustained-release theophylline preparations: Theo-Dur, Uni-Dur and Xanthium.
    Rojanasthien N, Kovjiriyapan K, Manorot M, Pothirat C.
    Asian Pac J Allergy Immunol; 2001 Jun 30; 19(2):69-78. PubMed ID: 11699723
    [Abstract] [Full Text] [Related]

  • 33. Bioavailability of sustained-release theophylline formulations.
    Bonora Regazzi M, Rondanelli R, Vidale E, Cristiani D.
    Int J Clin Pharmacol Ther Toxicol; 1983 May 30; 21(5):245-51. PubMed ID: 6862729
    [Abstract] [Full Text] [Related]

  • 34. [Bioavailability of a delayed-action aminophylline preparation].
    Regazzi MB, Guarnone E, Bartoli A, Ciardelli L, Piacentini P.
    Minerva Med; 1985 Mar 31; 76(13):641-5. PubMed ID: 3991030
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Studies on the sustained-release theophylline tablet].
    Mao FF, Tu XD, Zhu JB, Zhu YP.
    Yao Xue Xue Bao; 1986 Mar 31; 21(3):213-9. PubMed ID: 3788587
    [No Abstract] [Full Text] [Related]

  • 37. Comparative bio-availability of theophylline whole and halved sustained-release tablets.
    Müller FO, Hundt HK, Luus HG, van Dyk M, Groenewoud G, van der Meer MJ, Steinijans VW.
    S Afr Med J; 1987 Aug 01; 72(3):175-8. PubMed ID: 3299763
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics of sustained release theophylline in low and high multidose regimens.
    Koëter GH, Jonkman JH, de Vries K, Schoenmaker R, Greving JE, de Zeeuw RA.
    Br J Clin Pharmacol; 1981 Nov 01; 12(5):647-51. PubMed ID: 7332728
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.